The Use of a Combination Antibiogram to Assist with the Selection of Appropriate Antimicrobial Therapy for Carbapenemase-Producing Enterobacteriaceae Infections

Treating infections caused by carbapenemase-producing Enterobacteriaceae

(2014) L.S. Tzouvelekis et al.   CLINICAL MICROBIOLOGY AND INFECTION

Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients

(2011) S. M. Garonzik et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems?

(2011) G.L. Daikos et al.   CLINICAL MICROBIOLOGY AND INFECTION

Role of Unit-Specific Combination Antibiograms for Improving the Selection of Appropriate Empiric Therapy for Gram-Negative Pneumonia

(2011) Jason M. Pogue et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Efficacy and safety of tigecycline: a systematic review and meta-analysis

(2011) Dafna Yahav et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Stability of doripenem, imipenem and meropenem at elevated room temperatures

(2010) Rebecca A. Keel et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Efficacy of carbapenems against a metallo- -lactamase-producing Escherichia coli clinical isolate in a rabbit intra-abdominal abscess model

(2010) M. Souli et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution

(2009) Jason A. Roberts et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY